TetraLogic Pharmaceuticals Corp (TLOG)

[HokieHead]

This was a $6 stock 2 years ago with the same share structure.

TLOG is getting the following based upon Remetinostat's progression and it looks like it's on to phase 3 with FDA approval. HUGE!

The Company will be entitled to 5% of annual net sales from $0 to $500,000,000;

The Company will be entitled to 7.5% of annual net sales from $500,000,000 to $1,000,000,000;

The Company will be entitled to 10% of annual net sales above $1,000,000,000 .

Medivir has agreed to pay Tetralogic $12 million upfront, up to $20 million tied to remetinostat achieving development milestones through regulatory filings; up to $45 million tied to remetinostat winning regulatory approval milestones; and up to $31 million tied to achieving additional commercialization milestones, primarily related to sales. Medivir has also agreed to pay tiered royalties capped at an aggregate of 13% on remetinostat sales.